Tas, F. Et Al. 2014. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients. MELANOMA RESEARCH , vol.24, no.5 , 475-479.

Tas, F., Karabulut, S., Bilgin, E., Tastekin, D., & Duranyildiz, D., (2014). Clinical significance of serum fibronectin and vitronectin levels in melanoma patients. MELANOMA RESEARCH , vol.24, no.5, 475-479.

Tas, Faruk Et Al. "Clinical significance of serum fibronectin and vitronectin levels in melanoma patients," MELANOMA RESEARCH , vol.24, no.5, 475-479, 2014

Tas, Faruk Et Al. "Clinical significance of serum fibronectin and vitronectin levels in melanoma patients." MELANOMA RESEARCH , vol.24, no.5, pp.475-479, 2014

Tas, F. Et Al. (2014) . "Clinical significance of serum fibronectin and vitronectin levels in melanoma patients." MELANOMA RESEARCH , vol.24, no.5, pp.475-479.

@article{article, author={Faruk TAŞ Et Al. }, title={Clinical significance of serum fibronectin and vitronectin levels in melanoma patients}, journal={MELANOMA RESEARCH}, year=2014, pages={475-479} }